Intuitive Surgical executive Mark Brosius sells shares via pre-set plan

Mark Brosius, Executive Vice President and Chief Manufacturing and Supply Chain Officer at Intuitive Surgical, sold shares in two tranches on September 8 and 9. The transactions, involving 46 and 23 shares respectively, were conducted under a pre-established Rule 10b5-1 trading plan scheduled to run until February 2027.

Despite the insider sales, Intuitive Surgical recently published a large-scale meta-analysis in the journal Annals of Surgery Open. The study, which analyzed over 14 million procedures including da Vinci robotic surgeries, reported that da Vinci procedures showed a 69 percent lower probability of requiring blood transfusions compared to open surgery.